Capital MS&L wins healthcare brief

Ultrasis, which produces software to help combat various medical conditions, has ended an 18-month relationship with Solihull-based Nyans Communications.

Capital MS&L will seek to raise the profile of Ultrasis’s products, and handle financial PR and investor relations. In particular, Capital MS&L will promote ‘Beating the Blues’, Ultrasis’s treatment option for people with mild and moderate depression that received NICE backing in February.

Ultrasis CEO Nigel Brabbins said Capital MS&L won the brief after a pitch that did not include Nyans.